Showing results (121-130 of 224) with videos related to
Sort By:
Pageof 23
The Journal of Infectious Diseases|October 9, 2025
Trichomonas vaginalis Among Cisgender Women Taking Doxycycline Postexposure ProphylaxisFredericka Albertina Sesay, Kevin Oware, Lauren R Violette, et al.The Lancet. HIV|July 23, 2017
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP StudyRenee Heffron, R Scott McClelland, Jennifer E Balkus, et al.AIDS (London, England)|February 10, 2018
In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?Kate M Mitchell, Dobromir Dimitrov, James P Hughes, et al.The Journal of Infectious Diseases|November 13, 2014
Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couplesErin M Kahle, Michael Bolton, James P Hughes, et al.BMJ Open|October 1, 2017
Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) studyJienchi Dorward, Nigel Garrett, Justice Quame-Amaglo, et al.Journal of the International AIDS Society|September 7, 2023
Partner testing with HIV self-test distribution by Ugandan pregnant women living with HIV: a randomized trialAndrew Mujugira, Agnes Nakyanzi, Deborah Donnell, et al.Journal of the International AIDS Society|June 26, 2023
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in womenDeborah Donnell, Fei Gao, James P Hughes, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2015
Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 InfectionLaura Pattacini, Jared M Baeten, Katherine K Thomas, et al.The Lancet. Global Health|October 2, 2017
Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trialRanjeeta Thomas, Ronelle Burger, Abigail Harper, et al.The Lancet. Global Health|November 19, 2021
Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trialElizabeth M Irungu, Kenneth K Mugwanya, Nelly R Mugo, et al.Pageof 23